GBP/USD 1.360 EUR/GBP 0.862 GBP/JPY 199.387 EUR/USD 1.172 GBP/AUD 2.082 USD/JPY 146.626 USD/CAD 1.368 AUD/USD 0.653 CAD/JPY 107.148 EUR/CAD 1.603 GBP/CAD 1.861 AUD/CAD 0.894 AUD/JPY 95.775 AUD/NZD 1.088 EUR/AUD 1.794 GBP/USD 1.360 EUR/GBP 0.862 GBP/JPY 199.387 EUR/USD 1.172 GBP/AUD 2.082 USD/JPY 146.626 USD/CAD 1.368 AUD/USD 0.653 CAD/JPY 107.148 EUR/CAD 1.603 GBP/CAD 1.861 AUD/CAD 0.894 AUD/JPY 95.775 AUD/NZD 1.088 EUR/AUD 1.794
CURRENCY .wiki

Finance News – Pharmaceuticals

What is your interest today?

ABC News Business • Jul 08, 2025

PBS 'not on the table' to escape concerning pharmaceuticals tariff

The government remains committed to maintaining the current drug subsidy program despite potential economic challenges posed by a significant tariff increase on pharmaceutical expo...

Read Full Article →
ABC News Business • Jul 08, 2025

Live: Australia 'urgently' seeking further detail on Trump's pharmaceutical tariffs

Australia is actively requesting more information from the United States regarding the potential imposition of high tariffs on pharmaceutical imports, which could substantially imp...

Read Full Article →
BBC Business • Jul 08, 2025

US will hike tariffs on copper to 50%, Trump says

Increasing tariffs on copper and potentially other key industries such as pharmaceuticals, lumber, and semiconductors could significantly impact trade costs and market prices acros...

Read Full Article →
ABC News Business • Jul 08, 2025

Trump flags tariffs of 200pc on pharmaceuticals, 50pc on copper

A proposed increase in tariffs on pharmaceuticals and copper could substantially impact Australia's export revenues by significantly raising costs for these key commodities in the...

Read Full Article →
CNBC Business • Jul 08, 2025

Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon'

The potential introduction of substantial tariffs on pharmaceutical products could considerably affect pricing structures and market dynamics, with implementation possibly delayed...

Read Full Article →
Quartz • Jun 27, 2025

The weight loss drug boom has barely begun. How big can it get?

The rising popularity of GLP-1 medications, including Ozempic, positions them to generate substantial revenue, potentially surpassing established blockbuster drugs like statins in...

Read Full Article →
City A.M. • Jun 19, 2025

UK business set to gain big from India trade deal, says minister

The recently established trade agreement between the UK and India is expected to enhance economic opportunities for companies in sectors like finance, healthcare, and education by...

Read Full Article →
Quartz • Jun 09, 2025

Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices

Pfizer’s reluctance to guarantee reduced medication costs highlights ongoing challenges in achieving significant price cuts despite recent government efforts aimed at lowering expe...

Read Full Article →
Euronews Business • May 13, 2025

Bayer shares soar as company records strong cancer drug demand

Bayer’s pharmaceutical segment significantly boosted its revenue in the first quarter, contributing to a notable increase in share value despite underperformance in the agricultura...

Read Full Article →
Business Insider Markets • May 13, 2025

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Fennec Pharmaceuticals demonstrated increased income during the initial quarter of 2025, driven by strategic sales efforts and improved assistance for patients, reflecting overall...

Read Full Article →
CNBC Business • May 05, 2025

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.

Read Full Article →
The Guardian – Business • May 05, 2025

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Imposing tariffs on pharmaceutical imports could disrupt supply chains and increase medication costs, potentially making essential treatments less accessible for many individuals a...

Read Full Article →